Muna Anwar Alnimri, M.B.B.S.
Professor of Medicine
To see if Muna Anwar Alnimri is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Department
Locations and Contact
UC Davis Medical Center - Cypress Building
UC Davis Medical Center - Cypress Building
2221 Stockton Blvd.
Sacramento, CA 95817
Phone: 800-2-UCDAVIS (800-282-3284)
Additional Numbers
Clinic Phone
Clinic Fax
Physician Referrals
Philosophy of Care
I believe that patients can contribute to their own health care and help make decisions easier by interacting with their physicians as direct communication with health care providers build trust needed for excellent outcomes.
Clinical Interests
Dr. Alnimri is a Transplant Nephrologist offering care to adults with kidney and Pancreas transplant. She evaluates patients for kidney and pancreas transplant and those interested in living kidney donation.
Research/Academic Interests
Dr. Alnimri is interested in clinical trials about new immunosuppression in th pipline, follow up of living kidney donors, diagnosing rejection without doing kidney biopsies, and treatment for BK Nephropathy.
Division
Transplant Nephrology
Nephrology
Center/Program Affiliation
Medical School
M.B.B.S., Jordan University School of Medicine, Amman, Jordan 1987
Internship
Internal Medicine, Unity Health System, Rochester NY 2006-2008
Residency
Internal Medicine, Unity Health System, Rochester NY 2006-2008
Fellowship
Nephrology, Oregon Health Sciences University, Portland OR 1997-1999
Fellowship
Transplant Nephrology, UC San Francisco, San Francisco CA 2008-2009
Fellow of the Royal College of Physicians UK, 2005
Honorary Registrar University College, London, 2001
Diamond Doctor Award, UC Davis, 2024,
Reddy L, Thompson G, Tuznik N, Ho D, Zolfaghari T, Voyspanich J, Aims J, Crabtree S, Fine J, Wilson M, Alnimri M, Cohen S, Koff A. Safety of Fluconazole in Kidney Transplant Recipients For Prevention of Coccidioidomycosis, Medical Mycology. 2024; 017.
Koff A, Narsana N, Alnimri M. Maribavir use in Patients with renal impairment, Transplant Journal of Infectious Disease. 2023; vol 25, issue3/e14017.
Jespersen Nizamic T, Huang Y, Alnimri M, Cheng M, Chen LX, Jen KY. COVID-19 Manifesting as Renal Allograft Dysfunction, Acute Pancreatitis, and Thrombotic Microangiopathy: A Case Report. Transplant Proc. 2021 May;53(4):1211-1214. doi:10.1016/j.transproceed.2020.10.048. Epub 2020 Dec 18. PMID:33436168.
Howard JH 3rd, Darrow M, Chen LX, Alnimri M, Jen KY. Tonsillar Kaposi sarcoma in a renal transplant patient. Transpl Infect Dis. 2020 Oct;22(5):e13347. doi:10.1111/tid.13347. Epub 2020 Jun 16. PMID:32495980.
Freidman G, Moss O, Alnimri M, Chen L. Determination of type 2 DM risk in potential living kidney donors : A single center protocol and experience. Transplantation. 2020 Sep;104(S3):S87-S88.
Chen LX, De Mattos A, Bang H, Vu CT, Gandhi M, Alnimri M, Gallay B, Fananapazir G. Angioplasty vs stent in the treatment of transplant renal artery stenosis. Clin Transplant. 2018 Apr;32(4):e13217. doi:10.1111/ctr.13217. Epub 2018 Feb 28. PMID:29394514.
Patel S, Pankewycz O, Kohli R, Said M, Alnimri M, Feng L, Laftavi MR. Obesity in renal transplantation: the role of induction therapy on long-term outcomes. Transplant Proc. 2011 Mar;43(2):469-71. doi:10.1016/j.transproceed.2011.01.040. PMID:21440736.
Alnimri M, Laftavi MR, Kohli R, Said M, Feng L, Patel S, Pankewycz O. African-American women and older patients are at risk for a greater decline in renal function following living kidney donation. Transplant Proc. 2011 Mar;43(2):512-5. doi:10.1016/j.transproceed.2011.01.041. PMID:21440747.
Laftavi MR, Alnimri M, Weber-Shrikant E, Kohli R, Said M, Patel S, Pankewycz O. Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up. Transplant Proc. 2011 Mar;43(2):458-61. doi:10.1016/j.transproceed.2011.01.035. PMID:21440733.
Laftavi MR, Patel S, Soliman MR, Alnimri M, Kohli R, Said M, Pankewycz O. Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy. Transplant Proc. 2011 Mar;43(2):466-8. doi:10.1016/j.transproceed.2011.01.039. PMID:21440735.